{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:49:04Z","timestamp":1772160544268,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,22]]},"DOI":"10.7759\/cureus.45794","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T23:50:16Z","timestamp":1695426616000},"source":"Crossref","is-referenced-by-count":4,"title":["A Narrative Review on the Efficacy and Safety of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction"],"prefix":"10.7759","author":[{"given":"Ruth","family":"Pius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"God-dowell O","family":"Odukudu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Olorundare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah I","family":"Makanjuola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Komolafe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidimma","family":"Njoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ogheneakpobor E","family":"Ubogun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramatu","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsie O","family":"Osiogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb","family":"Anulaobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022, 145:e895-e1032. 10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-022-01221-z","article-title":"Integrative analyses of biomarkers and pathways for heart failure","volume":"15","author":"Fan S","year":"2022","unstructured":"Fan S, Hu Y. Integrative analyses of biomarkers and pathways for heart failure. BMC Med Genomics. 2022, 15:72. 10.1186\/s12920-022-01221-z","journal-title":"BMC Med Genomics"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and Stroke Statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani SS","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, et al.. Heart disease and Stroke Statistics-2020 update: a report from the American Heart Association. Circulation. 2020, 141:e139-596. 10.1161\/CIR.0000000000000757","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo M","year":"2020","unstructured":"Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, Mebazaa A. Acute heart failure. Nat Rev Dis Primers. 2020, 6:16. 10.1038\/s41572-020-0151-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1253\/circrep.CR-19-0012","article-title":"Comparison of long-acting and short-acting loop diuretics in the treatment of heart failure with preserved ejection fraction","volume":"1","author":"Suzuki S","year":"2019","unstructured":"Suzuki S, Motoki H, Kanzaki Y, et al.. Comparison of long-acting and short-acting loop diuretics in the treatment of heart failure with preserved ejection fraction. Circ Rep. 2019, 1:137-41. 10.1253\/circrep.CR-19-0012","journal-title":"Circ Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2016.01.005","article-title":"Volume overload profiles in patients with preserved and reduced ejection fraction chronic heart failure: are there differences? A pilot study","volume":"4","author":"Miller WL","year":"2016","unstructured":"Miller WL, Mullan BP. Volume overload profiles in patients with preserved and reduced ejection fraction chronic heart failure: are there differences? A pilot study. JACC Heart Fail. 2016, 4:453-9. 10.1016\/j.jchf.2016.01.005","journal-title":"JACC Heart Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01779-7","article-title":"Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF","volume":"110","author":"Simonavi\u010dius J","year":"2021","unstructured":"Simonavi\u010dius J, Maeder MT, Eurlings CG, et al.. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF. Clin Res Cardiol. 2021, 110:1221-33. 10.1007\/s00392-020-01779-7","journal-title":"Clin Res Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1796","article-title":"Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry","volume":"22","author":"Kapelios CJ","year":"2020","unstructured":"Kapelios CJ, Laroche C, Crespo-Leiro MG, et al.. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry. Eur J Heart Fail. 2020, 22:1424-37. 10.1002\/ejhf.1796","journal-title":"Eur J Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.crvasa.2017.09.007","article-title":"[Increased dose of diuretics correlates with severity of heart failure and renal dysfunction and does not lead to reduction of mortality and rehospitalizations due to acute decompensation of heart failure; data from AHEAD registry]","volume":"60","author":"Pavlusova M","year":"2018","unstructured":"Pavlusova M, Miklik R, Spacek R, et al.. [Increased dose of diuretics correlates with severity of heart failure and renal dysfunction and does not lead to reduction of mortality and rehospitalizations due to acute decompensation of heart failure; data from AHEAD registry]. Cor et Vasa. 2018, 60:e215-23. 10.1016\/j.crvasa.2017.09.007","journal-title":"Cor et Vasa"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2018.06.017","article-title":"Loop diuretic adjustments in patients with chronic heart failure: insights from HF-ACTION","volume":"205","author":"Fudim M","year":"2018","unstructured":"Fudim M, O'Connor CM, Mulder H, et al.. Loop diuretic adjustments in patients with chronic heart failure: insights from HF-ACTION. Am Heart J. 2018, 205:133-41. 10.1016\/j.ahj.2018.06.017","journal-title":"Am Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker GM","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, et al.. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011, 364:797-805. 10.1056\/NEJMoa1005419","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2019.01.014","article-title":"Comparing torsemide versus furosemide in patients with heart failure: a meta-analysis","volume":"59","author":"Kido K","year":"2019","unstructured":"Kido K, Shimizu M, Hashiguchi M. Comparing torsemide versus furosemide in patients with heart failure: a meta-analysis. J Am Pharm Assoc (2003). 2019, 59:432-8. 10.1016\/j.japh.2019.01.014","journal-title":"J Am Pharm Assoc (2003)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-021-00538-7","article-title":"Impact of loop diuretic on outcomes in patients with heart failure and reduced ejection fraction","volume":"19","author":"Antonietta CM","year":"2022","unstructured":"Antonietta CM, Calvi E, Faggiano A, et al.. Impact of loop diuretic on outcomes in patients with heart failure and reduced ejection fraction. Curr Heart Fail Rep. 2022, 19:15-25. 10.1007\/s11897-021-00538-7","journal-title":"Curr Heart Fail Rep"},{"key":"ref14","article-title":"Heart failure: pathophysiology and diagnosis","author":"Givertz MM","year":"2022","unstructured":"Givertz MM, Mehra MR. Heart failure: pathophysiology and diagnosis. Harrison's Principles of Internal Medicine, 21e. Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J (ed): McGraw Hill, New York, NY; 2022."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee J","year":"2017","unstructured":"Hartupee J, Mann DL. Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol. 2017, 14:30-8. 10.1038\/nrcardio.2016.163","journal-title":"Nat Rev Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-013-0155-7","article-title":"The emerging epidemic of heart failure with preserved ejection fraction","volume":"10","author":"Oktay AA","year":"2013","unstructured":"Oktay AA, Rich JD, Shah SJ. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013, 10:401-10. 10.1007\/s11897-013-0155-7","journal-title":"Curr Heart Fail Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01347","article-title":"Microvascular dysfunction in heart failure with preserved ejection fraction","volume":"10","author":"D'Amario D","year":"2019","unstructured":"D'Amario D, Migliaro S, Borovac JA, et al.. Microvascular dysfunction in heart failure with preserved ejection fraction. Front Physiol. 2019, 10:1347. 10.3389\/fphys.2019.01347","journal-title":"Front Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart failure with preserved ejection fraction in perspective","volume":"124","author":"Pfeffer MA","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019, 124:1598-617. 10.1161\/CIRCRESAHA.119.313572","journal-title":"Circ Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00638","article-title":"Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology","volume":"10","author":"Gevaert AB","year":"2019","unstructured":"Gevaert AB, Boen JR, Segers VF, Van Craenenbroeck EM. Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology. Front Physiol. 2019, 10:638. 10.3389\/fphys.2019.00638","journal-title":"Front Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-017-0219-2","article-title":"Management of heart failure with preserved ejection fraction: current challenges and future directions","volume":"17","author":"Upadhya B","year":"2017","unstructured":"Upadhya B, Kitzman DW. Management of heart failure with preserved ejection fraction: current challenges and future directions. Am J Cardiovasc Drugs. 2017, 17:283-98. 10.1007\/s40256-017-0219-2","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09630818","article-title":"Clinical pharmacology in diuretic use","volume":"14","author":"Ellison DH","year":"2019","unstructured":"Ellison DH. Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol. 2019, 14:1248-57. 10.2215\/CJN.09630818","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref22","article-title":"Drugs affecting renal excretory function","author":"Jackson EK","year":"2017","unstructured":"Jackson EK. Drugs affecting renal excretory function. The Pharmacological Basis of Therapeutics. Brunton LL, Hilal-Dandan R, Knollmann BC (ed): McGraw Hill, New York, NY; 2017."},{"key":"ref23","article-title":"Loop diuretics","author":"Huxel C","year":"2023","unstructured":"Huxel C, Raja A, Ollivierre-Lawrence MD. Loop diuretics. StatPearls. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1310\/hpj5006-454","article-title":"Treating heart failure with preserved ejection fraction: a challenge for clinicians","volume":"50","author":"Howard PA","year":"2015","unstructured":"Howard PA. Treating heart failure with preserved ejection fraction: a challenge for clinicians. Hosp Pharm. 2015, 50:454-9. 10.1310\/hpj5006-454","journal-title":"Hosp Pharm"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v6.i2.67","article-title":"Therapeutic interventions for heart failure with preserved ejection fraction: a summary of current evidence","volume":"6","author":"Asrar ul Haq M","year":"2014","unstructured":"Asrar ul Haq M, Wong C, Mutha V, Anavekar N, Lim K, Barlis P, Hare DL. Therapeutic interventions for heart failure with preserved ejection fraction: a summary of current evidence. World J Cardiol. 2014, 6:67-76. 10.4330\/wjc.v6.i2.67","journal-title":"World J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.01.109","article-title":"Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - a multicenter propensity score matched analysis","volume":"289","author":"T\u00e4ger T","year":"2019","unstructured":"T\u00e4ger T, Fr\u00f6hlich H, Grundtvig M, et al.. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - a multicenter propensity score matched analysis. Int J Cardiol. 2019, 289:83-90. 10.1016\/j.ijcard.2019.01.109","journal-title":"Int J Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.23924","article-title":"Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the transform-HF randomized clinical trial","volume":"329","author":"Mentz RJ","year":"2023","unstructured":"Mentz RJ, Anstrom KJ, Eisenstein EL, et al.. Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the transform-HF randomized clinical trial. JAMA. 2023, 329:214-23. 10.1001\/jama.2022.23924","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14030","article-title":"Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization","volume":"9","author":"Imaeda S","year":"2022","unstructured":"Imaeda S, Shiraishi Y, Kohsaka S, et al.. Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization. ESC Heart Fail. 2022, 9:2967-77. 10.1002\/ehf2.14030","journal-title":"ESC Heart Fail"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.06.022","article-title":"Loop diuretic prescription and 30-day outcomes in older patients with heart failure","volume":"76","author":"Faselis C","year":"2020","unstructured":"Faselis C, Arundel C, Patel S, et al.. Loop diuretic prescription and 30-day outcomes in older patients with heart failure. J Am Coll Cardiol. 2020, 76:669-79. 10.1016\/j.jacc.2020.06.022","journal-title":"J Am Coll Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01598-w","article-title":"Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction","volume":"109","author":"Ter Maaten JM","year":"2020","unstructured":"Ter Maaten JM, Martens P, Damman K, et al.. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction. Clin Res Cardiol. 2020, 109:1048-59. 10.1007\/s00392-020-01598-w","journal-title":"Clin Res Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8111854","article-title":"Loop diuretic administration in patients with acute heart failure and reduced systolic function: effects of different intravenous diuretic doses and diuretic response measurements","volume":"8","author":"Ruocco G","year":"2019","unstructured":"Ruocco G, Feola M, Nuti R, Luschi L, Evangelista I, Palazzuoli A. Loop diuretic administration in patients with acute heart failure and reduced systolic function: effects of different intravenous diuretic doses and diuretic response measurements. J Clin Med. 2019, 8:1854. 10.3390\/jcm8111854","journal-title":"J Clin Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014657","article-title":"Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function","volume":"98","author":"Onitsuka H","year":"2019","unstructured":"Onitsuka H, Koyama S, Ideguchi T, Ishikawa T, Kitamura K, Nagamachi S. Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function. Medicine (Baltimore). 2019, 98:e14657. 10.1097\/MD.0000000000014657","journal-title":"Medicine (Baltimore)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13453","article-title":"Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction","volume":"8","author":"He X","year":"2021","unstructured":"He X, Dong B, Xue R, et al.. Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction. ESC Heart Fail. 2021, 8:3248-56. 10.1002\/ehf2.13453","journal-title":"ESC Heart Fail"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/medicines7050030","article-title":"Heart failure drug class effects on 30-day readmission rates in patients with heart failure with preserved ejection fraction: a retrospective single center study","volume":"7","author":"Parajuli P","year":"2020","unstructured":"Parajuli P, Lara-Garcia OE, Regmi MR, Skoza W, Bhattarai M, Kulkarni A, Robinson RL. Heart failure drug class effects on 30-day readmission rates in patients with heart failure with preserved ejection fraction: a retrospective single center study. Medicines (Basel). 2020, 7:30. 10.3390\/medicines7050030","journal-title":"Medicines (Basel)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.04.008","article-title":"Randomized evaluation of heart failure with preserved ejection fraction patients with acute heart failure and dopamine: the Ropa-DOP trial","volume":"6","author":"Sharma K","year":"2018","unstructured":"Sharma K, Vaishnav J, Kalathiya R, et al.. Randomized evaluation of heart failure with preserved ejection fraction patients with acute heart failure and dopamine: the Ropa-DOP trial. JACC Heart Fail. 2018, 6:859-70. 10.1016\/j.jchf.2018.04.008","journal-title":"JACC Heart Fail"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox CS","year":"2020","unstructured":"Wilcox CS, Testani JM, Pitt B. Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure. Hypertension. 2020, 76:1045-54. 10.1161\/HYPERTENSIONAHA.120.15205","journal-title":"Hypertension"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185050-a-narrative-review-on-the-efficacy-and-safety-of-loop-diuretics-in-patients-with-heart-failure-with-reduced-ejection-fraction-and-preserved-ejection-fraction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:55Z","timestamp":1707508195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185050-a-narrative-review-on-the-efficacy-and-safety-of-loop-diuretics-in-patients-with-heart-failure-with-reduced-ejection-fraction-and-preserved-ejection-fraction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.45794","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,22]]}}}